Annual Operating Expenses
$4.45 B
+$168.00 M+3.92%
31 December 2023
Summary:
Teva Pharmaceutical Industries Limited annual total operating expenses is currently $4.45 billion, with the most recent change of +$168.00 million (+3.92%) on 31 December 2023. During the last 3 years, it has fallen by -$217.00 million (-4.65%). TEVA annual operating expenses is now -36.87% below its all-time high of $7.05 billion, reached on 31 December 2016.TEVA Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$1.16 B
-$44.00 M-3.64%
30 September 2024
Summary:
Teva Pharmaceutical Industries Limited quarterly total operating expenses is currently $1.16 billion, with the most recent change of -$44.00 million (-3.64%) on 30 September 2024. Over the past year, it has increased by +$67.00 million (+6.11%). TEVA quarterly operating expenses is now -49.33% below its all-time high of $2.30 billion, reached on 31 December 2008.TEVA Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TEVA Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.9% | +6.1% |
| 3 y3 years | -4.7% | +7.3% |
| 5 y5 years | -18.0% | +5.2% |
TEVA Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -4.7% | +3.9% | -5.0% | +17.0% |
| 5 y | 5 years | -18.0% | +3.9% | -12.7% | +17.0% |
| alltime | all time | -36.9% | >+9999.0% | -49.3% | +1762.4% |
Teva Pharmaceutical Industries Limited Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.16 B(-3.6%) |
| June 2024 | - | $1.21 B(+7.0%) |
| Mar 2024 | - | $1.13 B(0.0%) |
| Dec 2023 | $4.45 B(+3.9%) | $1.13 B(+2.9%) |
| Sept 2023 | - | $1.10 B(-4.6%) |
| June 2023 | - | $1.15 B(+7.1%) |
| Mar 2023 | - | $1.07 B(-5.4%) |
| Dec 2022 | $4.28 B(-4.7%) | $1.14 B(+14.1%) |
| Sept 2022 | - | $995.00 M(-9.6%) |
| June 2022 | - | $1.10 B(+4.6%) |
| Mar 2022 | - | $1.05 B(-14.0%) |
| Dec 2021 | $4.50 B(-3.7%) | $1.23 B(+12.9%) |
| Sept 2021 | - | $1.08 B(+2.2%) |
| June 2021 | - | $1.06 B(-5.5%) |
| Mar 2021 | - | $1.12 B(-15.7%) |
| Dec 2020 | $4.67 B(-3.1%) | $1.33 B(+17.5%) |
| Sept 2020 | - | $1.13 B(+5.3%) |
| June 2020 | - | $1.08 B(-4.3%) |
| Mar 2020 | - | $1.13 B(-12.5%) |
| Dec 2019 | $4.82 B(-11.3%) | $1.29 B(+16.3%) |
| Sept 2019 | - | $1.11 B(-10.0%) |
| June 2019 | - | $1.23 B(+2.8%) |
| Mar 2019 | - | $1.20 B(-16.8%) |
| Dec 2018 | $5.43 B(-18.1%) | $1.44 B(+8.9%) |
| Sept 2018 | - | $1.32 B(+2.4%) |
| June 2018 | - | $1.29 B(-6.9%) |
| Mar 2018 | - | $1.38 B(+2.8%) |
| Dec 2017 | $6.62 B(-6.0%) | $1.35 B(-22.9%) |
| Sept 2017 | - | $1.75 B(-1.7%) |
| June 2017 | - | $1.78 B(+1.1%) |
| Mar 2017 | - | $1.76 B(-10.7%) |
| Dec 2016 | $7.05 B(+10.8%) | $1.97 B(+2.8%) |
| Sept 2016 | - | $1.91 B(+16.8%) |
| June 2016 | - | $1.64 B(+6.9%) |
| Mar 2016 | - | $1.53 B(-13.6%) |
| Dec 2015 | $6.36 B(-3.1%) | $1.77 B(+21.8%) |
| Sept 2015 | - | $1.46 B(-7.3%) |
| June 2015 | - | $1.57 B(+0.6%) |
| Mar 2015 | - | $1.56 B(-8.4%) |
| Dec 2014 | $6.57 B(-2.7%) | $1.71 B(+3.0%) |
| Sept 2014 | - | $1.66 B(+5.6%) |
| June 2014 | - | $1.57 B(-4.4%) |
| Mar 2014 | - | $1.64 B(-11.8%) |
| Dec 2013 | $6.75 B(+4.2%) | $1.86 B(+15.0%) |
| Sept 2013 | - | $1.62 B(-1.5%) |
| June 2013 | - | $1.64 B(+0.6%) |
| Mar 2013 | - | $1.63 B(-10.2%) |
| Dec 2012 | $6.47 B(+17.6%) | $1.82 B(+18.7%) |
| Sept 2012 | - | $1.53 B(-4.1%) |
| June 2012 | - | $1.59 B(+4.1%) |
| Mar 2012 | - | $1.53 B(-11.0%) |
| Dec 2011 | $5.50 B(+15.1%) | $1.72 B(+48.4%) |
| Sept 2011 | - | $1.16 B(-12.8%) |
| June 2011 | - | $1.33 B(+3.0%) |
| Mar 2011 | - | $1.29 B(-5.5%) |
| Dec 2010 | $4.78 B(+11.2%) | $1.37 B(+11.5%) |
| Sept 2010 | - | $1.23 B(+17.8%) |
| June 2010 | - | $1.04 B(-8.8%) |
| Mar 2010 | - | $1.14 B(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $4.30 B(-8.5%) | $1.19 B(+10.3%) |
| Sept 2009 | - | $1.08 B(+6.2%) |
| June 2009 | - | $1.01 B(-0.4%) |
| Mar 2009 | - | $1.02 B(-55.6%) |
| Dec 2008 | $4.70 B(+89.3%) | $2.30 B(+172.8%) |
| Sept 2008 | - | $842.00 M(-2.9%) |
| June 2008 | - | $867.00 M(+25.1%) |
| Mar 2008 | - | $693.00 M(+1.0%) |
| Dec 2007 | $2.48 B(+14.7%) | $686.00 M(+14.5%) |
| Sept 2007 | - | $599.00 M(-1.2%) |
| June 2007 | - | $606.00 M(+2.5%) |
| Mar 2007 | - | $591.00 M(-13.1%) |
| Dec 2006 | $2.16 B(+85.2%) | $679.80 M(+26.3%) |
| Sept 2006 | - | $538.10 M(+8.5%) |
| June 2006 | - | $496.10 M(+18.7%) |
| Mar 2006 | - | $418.00 M(+32.4%) |
| Dec 2005 | $1.17 B(+9.8%) | $315.60 M(+3.0%) |
| Sept 2005 | - | $306.40 M(+12.2%) |
| June 2005 | - | $273.20 M(+0.1%) |
| Mar 2005 | - | $272.80 M(-2.5%) |
| Dec 2004 | $1.06 B(+67.8%) | $279.70 M(+2.9%) |
| Sept 2004 | - | $271.90 M(+6.1%) |
| June 2004 | - | $256.20 M(0.0%) |
| Mar 2004 | - | $256.20 M(+24.1%) |
| Dec 2003 | $634.10 M(+11.0%) | $206.50 M(+14.7%) |
| Sept 2003 | - | $180.10 M(+129.7%) |
| June 2003 | - | $78.40 M(-53.6%) |
| Mar 2003 | - | $169.10 M(+8.0%) |
| Dec 2002 | $571.40 M(+21.4%) | $156.60 M(+5.1%) |
| Sept 2002 | - | $149.00 M(+10.0%) |
| June 2002 | - | $135.50 M(+4.0%) |
| Mar 2002 | - | $130.30 M(+1.7%) |
| Dec 2001 | $470.84 M(+14.4%) | $128.14 M(+20.1%) |
| Sept 2001 | - | $106.70 M(-9.5%) |
| June 2001 | - | $117.89 M(-0.1%) |
| Mar 2001 | - | $118.06 M(-5.3%) |
| Dec 2000 | $411.65 M(+30.4%) | $124.72 M(+17.8%) |
| Sept 2000 | - | $105.91 M(-14.6%) |
| June 2000 | - | $124.06 M(+52.1%) |
| Mar 2000 | - | $81.58 M(-10.4%) |
| Dec 1999 | $315.73 M(+14.4%) | $91.03 M(+18.5%) |
| Sept 1999 | - | $76.80 M(+0.9%) |
| June 1999 | - | $76.10 M(+5.8%) |
| Mar 1999 | - | $71.90 M(+1.3%) |
| Dec 1998 | $276.09 M(-12.1%) | $70.99 M(-8.5%) |
| Sept 1998 | - | $77.60 M(+19.2%) |
| June 1998 | - | $65.10 M(+4.2%) |
| Mar 1998 | - | $62.50 M |
| Dec 1997 | $314.20 M(+14.6%) | - |
| Dec 1996 | $274.10 M(+21.5%) | - |
| Dec 1995 | $225.60 M(+8.1%) | - |
| Dec 1994 | $208.60 M(+43.4%) | - |
| Dec 1993 | $145.50 M(+23.5%) | - |
| Dec 1992 | $117.80 M(+45.6%) | - |
| Dec 1991 | $80.90 M(-16.9%) | - |
| Dec 1990 | $97.40 M(+73.3%) | - |
| Dec 1989 | $56.20 M(-4.9%) | - |
| Dec 1988 | $59.10 M(+66.9%) | - |
| Mar 1987 | $35.40 M(+72.7%) | - |
| Mar 1986 | $20.50 M | - |
FAQ
- What is Teva Pharmaceutical Industries Limited annual total operating expenses?
- What is the all time high annual operating expenses for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited annual operating expenses year-on-year change?
- What is Teva Pharmaceutical Industries Limited quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Teva Pharmaceutical Industries Limited?
- What is Teva Pharmaceutical Industries Limited quarterly operating expenses year-on-year change?
What is Teva Pharmaceutical Industries Limited annual total operating expenses?
The current annual operating expenses of TEVA is $4.45 B
What is the all time high annual operating expenses for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high annual total operating expenses is $7.05 B
What is Teva Pharmaceutical Industries Limited annual operating expenses year-on-year change?
Over the past year, TEVA annual total operating expenses has changed by +$168.00 M (+3.92%)
What is Teva Pharmaceutical Industries Limited quarterly total operating expenses?
The current quarterly operating expenses of TEVA is $1.16 B
What is the all time high quarterly operating expenses for Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited all-time high quarterly total operating expenses is $2.30 B
What is Teva Pharmaceutical Industries Limited quarterly operating expenses year-on-year change?
Over the past year, TEVA quarterly total operating expenses has changed by +$67.00 M (+6.11%)